Technology and platforms – Page 22 – Discover Pharma

Welcome to Discover Pharma! Today is : April 25, 2026

Technology and platforms

CDMOs & Manufacturing,Drug Development,Market Access & Commercialization,Partnerships & Funding,Technology and platforms
Sphere Bio enters China market with Redbert Biotechnology distribution deal
Sphere Bio has signed an exclusive distribution agreement with Redbert [...]

June 27, 2025
Artificial Intelligence,CDMOs & Manufacturing,Drug Development,Technology and platforms
AI can’t thrive in chaos: New survey finds labs still struggling with basics
A new industry survey has revealed that while life sciences [...]

June 27, 2025
Cell & Gene Therapy,Clinical Trials,Drug Development,Oncology,Technology and platforms
Galapagos CAR-T therapy shows strong results in relapsed indolent NHL
Galapagos has announced promising results from Cohort 3 of its [...]

June 27, 2025
CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development,Oncology,Precision medicine,Technology and platforms
Galapagos taps CELLforCURE by SEQENS to manufacture CAR-T therapy in France
CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

June 27, 2025
CDMOs & Manufacturing,Drug Development,Oncology,Technology and platforms
Orano Med invests $5M to expand US radiopharma capabilities
Orano Med has expanded its US research and development center [...]

June 27, 2025
CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development,Oncology,Partnerships & Funding,Technology and platforms
Mabion manufactures first batch of NovalGen’s bispecific T-cell engager for clinical trials
Poland-based CDMO Mabion has completed the first GMP-compliant batch of [...]

June 27, 2025
Artificial Intelligence,Drug Development,Patient Centricity,Technology and platforms
Prenuvo research links alcohol and exercise to early brain and organ changes in asymptomatic adults
Two new studies presented at the 2025 ISMRM Annual Meeting [...]

June 27, 2025
Artificial Intelligence,Clinical Trials,Patient Centricity,Precision medicine,Regulatory Affairs,Technology and platforms
Rejoyn becomes first prescription-only app for depression in Great Britain with its mode of action
Clinically validated digital therapeutic launches with UKCA mark and NHS [...]

June 30, 2025
Artificial Intelligence,Clinical Trials,Drug Delivery & Formulation,Market Access & Commercialization,Partnerships & Funding,Precision medicine,Technology and platforms
Faction imaging secures $10M to reinvent AI-native medical imaging infrastructure
Backed by Nodenza Venture Partners, the stealth-mode innovator emerges with [...]

June 26, 2025
Clinical Trials,Drug Delivery & Formulation,Oncology,Patient Centricity,Precision medicine,Technology and platforms
Can cryoablation plus intratumora immunotherapy rewrite the rules of cancer treatment?
Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

June 26, 2025